Products
Online Inquiry
Voacamine
Inquiry
Cat. No.:
OB0425LY-400
Synonyms:
Voacanginine; 3371-85-5; Methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate; Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate; Methyl (1S,15S,17S,18S)-17-ethyl-6-[(1R,12R,14R,15E)-15-ethylidene-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4,6,8-tetraen-12-yl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0^{2,10}.0^{4,9}.0^{13,18}]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
Size:
1 mg; 5 mg; 10 mg; 50 mg; 100 mg
CAS No.:
3371-85-5
Compound CID:
11953931
Specification
Description:
Voacamine is an indole alkaloid with antihypertensive and neuroprotective effects. It showing potential in treating cardiovascular and neurodegenerative disorders.
Formula Weight:
704.9
Applications:
Voacamine can be used to inhibit P-glycoprotein (P-gp) action in multidrug-resistant tumor cells.
Storage:
Storage at -20°C.
Formula:
C43H52N4O5
Appearance:
Solid
Purity:
99.64%, determined by LC-MS.
Solubility:
DMSO
Pathway:
GPCR/G protein; Neuronal signaling; Membrane transporter/Ion channel
Identity:
Confirmed by LC-MS.
Target:
Cannabinoid receptor; P-glycoprotein
Library Information
Solubility:
DMSO